Post Reply
181-200 of 8718
moving quickly, expected good results soon, hold your horses and own it fast
is TH moving up soon? 0.048 selling few lots, 0.047 many buying , earlier 0.049 2+million selling, quite unusual, perhpas somehing good creeping up soon
Thomson Medical Group (SGX:A50) investors are sitting on a loss of 43% if they invested three years ago
[email protected] (Simply Wall St)
Mon, 18 November 2024 at 9:40 am SGT 3 min read
this baby should be up and running hopefully
this baby should be up and running hopefully
PL belongs to yester years
So is Oei HL.
So is Oei HL.
with the son as vice chairman, should have power to power up the share price, pl perhaps retiring and act as backbencher, hopefully due diligence to perk up the performance of this laggard stock
Peter Lim probably need help with his Valencia football club. Beckham Int Maimi is now top in MLS league. Valencia is now rock bottom in Spanish league.
honesty ( Date: 12-Nov-2024 09:10) Posted:
|
hopefully this news brings in hope for the rock bottom share price
https://mothership.sg/2024/11/david-beckham-jj-lin-peter-lim-gather-singapore/
https://mothership.sg/2024/11/david-beckham-jj-lin-peter-lim-gather-singapore/
indeed pathetic for the stock not to move up when medical is everyone' s need, hopefully owner will think harder to move the value up
But don't expect much good news from.them. stock price is range bound below 5ct.
honesty ( Date: 11-Nov-2024 09:51) Posted:
|
FishermanSG ( Date: 11-Nov-2024 09:48) Posted:
|
Usually in mid Feb for 1/2 year results. Full year results in Mid Aug. Hope this helps. Few months also saw jobstreet few hat thomson med hiring iskandar Project CEO. But no news from there.
honesty ( Date: 07-Nov-2024 10:23) Posted:
|
any idea when next financial announcement, it seems not even wriggling a bit, hopefully the mgmt can invest fruitfully in some fruitful areas for higher returns to shareholders
Yes. You will be Fisher of Men.
Peter was told
Peter was told
Fisherman888 ( Date: 09-Oct-2024 14:41) Posted:
|
Today should have some movements and tomorrow continue to surge likely
Peter won t play his stock
He has John Mark and Matthew and even Paul playing. Perhaps Luke and James may join but hope Judas Iscariot won t create riot and betray him like he did to Jesus.
He has John Mark and Matthew and even Paul playing. Perhaps Luke and James may join but hope Judas Iscariot won t create riot and betray him like he did to Jesus.
FishermanSG ( Date: 02-Sep-2024 11:26) Posted:
|
Next to fly like jiutian
It still anchor at 5ct range. Wont move. Peter expecting 2nd grandchild soon. Playing with grand children not stocks
honesty ( Date: 27-Aug-2024 12:17) Posted:
|
wondering why the price is stagnant for months, medical is everyone' s needs, should also diversify into property developement in iskandar since there will be good potential with the JS-SEZ coupled with the good connection
Joelton ( Date: 27-Aug-2024 12:04) Posted:
|
Thomson Medical&rsquo s H2 net profit dips 2.5% to S$13.4 million
Revenue for the half-year period increases 6.6 per cent to S$183 million
HEALTHCARE provider Thomson Medical : A50 0% posted a net profit of S$13.4 million for the second half of its 2024 fiscal year ending Jun 30, a 2.5 per cent dip from the same period a year ago.
Revenue for the half-year period increased 6.6 per cent to S$183 million, mainly due to revenue contribution from Far East Medical Vietnam, which was acquired by the group at the end of last year.
Earnings per share came in at 0.051 Singapore cents, down from 0.052 cents a year ago.
The increase in revenue was partially offset by the termination of some project-related services in December last year, such as the management of vaccination centres and transitional care facilities in Singapore.
This was in addition to smaller contributions resulting from lower patient loads and case intensity, the termination of certain customer contracts as well as discounts given to customers in Malaysia, said Thomson Medical in its earnings results released via a bourse filing on Monday (Aug 26).
Other income jumped more than 700 per cent from the previous corresponding period to S$28.5 million, due to the reversal of impairment losses on investment property and development property that were recognised previously.
Staff costs increased, mainly attributable to the increase in headcount in Malaysia resulting from the increased operating capacity at Thomson Hospital Kota Damansara, as well as the recognition of staff costs at its Vietnam business.
For the full year, net profit declined by 57.8 per cent to S$15.4 million, while revenue slid 1.3 per cent to S$351.2 million compared with FY2023.
Earnings per share for FY2024 stood at 0.058 Singapore cents, compared with 0.138 cents a year ago.
Thomson Medical said in its latest earnings that the healthcare sector remains resilient as a result of demographic shifts and evolving needs, even though the overall economic outlook is facing volatility due to rising costs, unemployment risks and recession concerns.
Singapore faces increasing competition from Malaysia and Thailand and will focus on complex procedures to attract developed-market patients. Malaysia&rsquo s healthcare spending is set to grow rapidly with RM41.2 billion (S$12.3 billion) allocated to the sector in the country&rsquo s 2024 national budget, while Vietnam&rsquo s spending is projected to reach US$23.3 billion by 2025 and US$33.8 billion by 2030 due to demographic changes and rising demand for long-term care.
&ldquo The group is well-positioned to leverage these opportunities and become a leading regional player in Asean,&rdquo read its earnings update. &ldquo It is expanding its doctor network, enhancing digital patient engagement, and focusing on human capital development, alongside cross-learning and sharing clinical expertise across its markets. The group will also reinforce its leadership in fertility (treatments) and deepen its oncology expertise by establishing specialised centres of excellence.&rdquo
Thomson Medical said that it has spent the past few years making long-term investments to expand its Singapore offering and increase its capacity in Malaysia. It added that the company is &ldquo poised to drive synergies across its South-east Asia footprint and grow as a regional healthcare player&rdquo with the acquisition of Far East Medical Vietnam completed.
Thomson Medical, OUE Healthcare subsidiaries partner on surgery centre in Vietnam
It also aims to serve patients from Cambodia, Laos, Myanmar and Vietnam
FV HOSPITAL and O2 Healthcare have partnered to establish a surgical centre in Vietnam, which began operations on Thursday (Aug 15).
FV Hospital is the first 100 per cent foreign-invested hospital in the country, and is owned by mainboard-listed Thomson Medical : A50 +2.04%.
O2 Healthcare, a lung specialist group based in Singapore, is a subsidiary of Catalist-listed OUE Healthcare : 5WA 0%.
Representatives of Thomson Medical declined to provide details on the partnership, citing business confidentiality.
The centre, which is billed as the first regional thoracic surgery centre in Vietnam, is located at FV Hospital in Ho Chi Minh City but also aims to serve patients from Cambodia, Laos, and Myanmar.
The tie-up will enable more Singapore doctors to offer specialised treatments in an underserved part of the region.
Dr Su Jang Wen, a cardiothoracic surgeon and lung cancer specialist from O2 Healthcare, will lead the treatments.
Thomson Medical announced the acquisition of Far East Medical Vietnam, the owner and operator of a range of healthcare facilities in Vietnam, including FV Hospital, in July 2023 for a consideration of up to US$381.4 million. The transaction was completed in January 2024.